Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

Solventum plans software separation to become 'true medtech company'

6 August 2026 · By · Wire by Fusion42

Published

6 August 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at medtechdive.com →

◆ Verified

Fusion42 · 30 August 2026 · Fusion42 review

Solventum plans to separate its software business from its medtech operations to attract distinct investment and accelerate growth, positioning itself as a dedicated medtech company.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ ◆ The Wire takeaway

Solventum's split opens new funding paths exclusively for medtech founders focused on hardware and device innovation. You need to evaluate whether creating sharper operational focus through separation could accelerate your growth and attract specialised capital.

◆ Coverage

1 source · 6 Aug 2026

◆ Related on Wire

◆ Topics

Medtechmedtechsoftware-separationinvestment-shiftbusiness-structure